MedTrace Logo

Art and Physical Therapy in Pediatric HCT

NCT05441670 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-01-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effect of a combination of art therapy (AT) and physical therapy (PT) to PT only in children undergoing hematopoietic cell transplant (HCT). Each child will receive daily AT and PT or only PT for 5 days per week for 2 weeks. These sessions will begin approximately on day 15 following the transplant. Prior to starting the sessions and following 2-weeks of sessions, self-care and mobility skills will be measured. During each session, the following variables will be measured: heart rate variability (i.e., time between heart beats) using a small monitor on the chest (about the size of a quarter), walking distance using an accelerometer (similar to wearing a watch), and self-reported happiness and excitability. Although results cannot be guaranteed, it is expected that each group will benefit and demonstrate improvements in emotional state, self-care, and mobility skills.

Conditions

  • Hematopoietic Stem Cell Transplantation
  • Art Therapy
  • Physical Therapy

Interventions

BEHAVIORAL

Physical Therapy

30 minutes of Physical Therapy, Monday through Friday for 2 weeks

BEHAVIORAL

Art and Physical Therapy

45 minutes of Art Therapy followed by 30 minutes of Physical Therapy, Monday through Friday for 2 weeks

Sponsors & Collaborators

  • National Endowment for the Arts, United States

    collaborator FED

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Cindy Dodds, PhD · MUSC College of Health Professions

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-12
Primary Completion
2024-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05441670 on ClinicalTrials.gov